These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 22915447)

  • 61. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.
    Courtney C; Farrell D; Gray R; Hills R; Lynch L; Sellwood E; Edwards S; Hardyman W; Raftery J; Crome P; Lendon C; Shaw H; Bentham P;
    Lancet; 2004 Jun; 363(9427):2105-15. PubMed ID: 15220031
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Effect of Memantine on Cognitive Function and Behavioral and Psychological Symptoms in Mild-to-Moderate Alzheimer's Disease Patients.
    Zhang N; Wei C; Du H; Shi FD; Cheng Y
    Dement Geriatr Cogn Disord; 2015; 40(1-2):85-93. PubMed ID: 26066622
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
    Whitehead A; Perdomo C; Pratt RD; Birks J; Wilcock GK; Evans JG
    Int J Geriatr Psychiatry; 2004 Jul; 19(7):624-33. PubMed ID: 15254918
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.
    Feldman H; Gauthier S; Hecker J; Vellas B; Emir B; Mastey V; Subbiah P;
    J Am Geriatr Soc; 2003 Jun; 51(6):737-44. PubMed ID: 12757558
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.
    Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Ikeda M
    Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.
    Waring JF; Tang Q; Robieson WZ; King DP; Das U; Dubow J; Dutta S; Marek GJ; Gault LM
    J Alzheimers Dis; 2015; 47(1):137-48. PubMed ID: 26402762
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12-week multicentre, randomised, double-blind, and placebo-controlled phase IV study.
    Mori E; Ikeda M; Iseki E; Katayama S; Nagahama Y; Ohdake M; Takase T
    Psychogeriatrics; 2024 May; 24(3):542-554. PubMed ID: 38439118
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Donepezil for mild and moderate Alzheimer's disease.
    Birks JS; Melzer D; Beppu H
    Cochrane Database Syst Rev; 2000; (4):CD001190. PubMed ID: 11034704
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
    Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D
    Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
    Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
    Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia.
    Haig GM; Pritchett Y; Meier A; Othman AA; Hall C; Gault LM; Lenz RA
    J Alzheimers Dis; 2014; 42(3):959-71. PubMed ID: 25024314
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Donepezil for mild and moderate Alzheimer's disease.
    Birks J S; Melzer D
    Cochrane Database Syst Rev; 2000; (2):CD001190. PubMed ID: 10796620
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study.
    Ikeda M; Mori E; Kosaka K; Iseki E; Hashimoto M; Matsukawa N; Matsuo K; Nakagawa M;
    Dement Geriatr Cogn Disord; 2013; 36(3-4):229-41. PubMed ID: 23949147
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial.
    Fernandez HH; Weintraub D; Macklin E; Litvan I; Schwarzschild MA; Eberling J; Videnovic A; Kenney CJ;
    Parkinsonism Relat Disord; 2023 Sep; 114():105511. PubMed ID: 37532622
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.
    Winblad B; Kilander L; Eriksson S; Minthon L; Båtsman S; Wetterholm AL; Jansson-Blixt C; Haglund A;
    Lancet; 2006 Apr; 367(9516):1057-1065. PubMed ID: 16581404
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
    Krishnan KR; Charles HC; Doraiswamy PM; Mintzer J; Weisler R; Yu X; Perdomo C; Ieni JR; Rogers S
    Am J Psychiatry; 2003 Nov; 160(11):2003-11. PubMed ID: 14594748
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Donepezil.
    Bryson HM; Benfield P
    Drugs Aging; 1997 Mar; 10(3):234-9; discussion 240-1. PubMed ID: 9108896
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Utility of an effect size analysis for communicating treatment effectiveness: a case study of cholinesterase inhibitors for Alzheimer's disease.
    Peters KR
    J Am Geriatr Soc; 2013 Jul; 61(7):1170-4. PubMed ID: 23711226
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Donepezil in vascular dementia: a randomized, placebo-controlled study.
    Wilkinson D; Doody R; Helme R; Taubman K; Mintzer J; Kertesz A; Pratt RD;
    Neurology; 2003 Aug; 61(4):479-86. PubMed ID: 12939421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.